Abstract
Peste des Petits Ruminants (PPR) is a highly contagious animal disease caused by the Peste des Petits Ruminants virus (PPRV) belonging to the genus morbillivirus and family Paramyxoviridae. The disease results in high morbidity and mortality in goats, sheep and in some small wild ruminants. The presence of large number of small ruminants reared in endemic areas makes PPR a notorious disease threatening the livelihood of poor farmers. Conventional vaccination using a live, attenuated vaccine gives adequate protection but cannot be used in case of eradication of the disease due to difficulty in differentiation of infected animals from the vaccinated ones.
In the present study, we constructed two recombinant viruses using attenuated Modified Vaccinia virus Ankara virus (MVA) namely MVA-F and MVA-H expressing the full length PPRV fusion (F) and hemagglutinin (H) glycoproteins, respectively. Goats were vaccinated intramuscularly with 105 plaque forming units (PFU) each of the recombinant viruses and a live attenuated vaccine (RAKSHA PPR) and challenged 4 months later with PPRV challenge virus (103 goat LD50). All goats were completely protected from the clinical disease. This study gave an indication that mass vaccination of small ruminants with either of the above or both recombinant inexpensive virus vaccines could help in possible eradication of PPRV from endemic countries like India and subsequent seromonitoring of the disease for differentiation of infected animals from vaccinated ones.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Dhar P, Sreenivasa BP, Barrett T, Corteyn M, Singh RP and Bandyopadhyay SK (2002) Recent epidemiology of peste des petits ruminants virus PPRV. Vet Microbiol 88(2):153–159
Shaila MS, Purushothaman V, Bhavasar D, Venugopal K and Venkatesan RA (1989) Peste des petits ruminants in India. Vet Rec 125(24):602–606
Kumar A, Singh SV, Rana R, Vaid RK, Misri J and Vihan VS (2001) PPR outbreak in goats: epidemiological and therapeutic studies. Indian J Anim Sci 71(9):815–818
Singh RP, Sreenivasa BP and Bandyopadhyay SK (2002) Prevalence and distribution of peste des petits ruminants PPR virus infection in small ruminants of India. In Proc Indian Society for Sheep and Goat Production and Utilization ISSGPU, 5th National Seminar on strength, challenges and opportunities in small ruminant diseases in new millennium, 30–31 December, Jaipur ISSGPU, Jaipur, pp 130–134
Bandyopadhyay SK (2002) The economic appraisal of a PPR control programme in India. In 14th annual conference and national seminar on management of viral diseases with emphasis on global trade and WTO regime, Indian Virological Society, 18–20 January, Hebbal, Bangalore, Indian Virological Society, Hissar
Diallo A, Minet C, Le Goff C, Berhe G, Albina E, Libeau G and Barett T (2007) The threat of peste des petits ruminants: progress in vaccine development for disease control. Vaccine 25:5591–5597
Barrett T, Banyard AC and Diallo A (2005) Molecular biology of the morbilliviruses. In: Molecular biology of the morbillivirus. Barrett T, Pastoret PP, Taylor WP (Eds.), Academic Press, Elsevier, Amsterdam pp 31–67
Diallo A, Taylor WP, Lef’evre PC and Provost A (1989) Att’enuation d’une souche de virus de la peste des petits ruminants: candidat pour un vaccine homologue. Rev Elev M’ed v’et Pays Trop 42:311–317
Tsukiyama T, Yoshikawa Y, Kamata H, Imaoka H, Asano K, Funahashi S, Maruyama T, Shida H, Sugimoto M and Yamanouchi K (1989) Development of heat-stable recombinant rinderpest vaccine. Arch Virol 107:225–235
Stephensen CB, Welter J, Thaker SR, Taylor J, Tartaglia J and Paoletti E (1997) Canine distemper virus CDV infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J Virol 71:1506–1513
Romero CH, Barrett T, Evans SA, Kitching RP, Gershon PD, Bostock C and Black DN (1993) Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11:737–742
Romero CH, Barrett T, Chamberlain RW, Kitching RP, Fleming M and Black DN (1994) Recombinant capripoxvirus expressing the haemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 204:425–429
Moss B (1996) Genetically Engineered Poxviruses for Recombinant Gene Expression, Vaccination and Safety. PNAS USA 93:11341–11348
Mayr A (1967) Production of high quality interferons by means of strains of smallpox virus, which had been attenuated in cell culture passages. Zentralbl Bakteriol Mikrobiol Hyg Abt1 Orig B 183–190
Meyer H, Sutter G and Mayr A (1991) Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J Gen Virol 72: 1031–1038
Antoine G, Scheiflinger F, Dorner F and Falkner FG (1998) The Complete Genomic Sequence of the Modified Vaccinia Ankara Strain: Comparison with Other Orthopoxviruses. Virology 244:365–396
Carroll M and Moss B (1997) Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line. Virology 238:198–211
Drexler I, Heller K, Wahren B, Erfle V and Sutter G (1998) Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol 79:347–352
Blanchard TJ, Alcami A, Andrea P and Smith GL (1998) Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol 79:1159–1167
Sutter G and Moss B (1992) Nonreplicating vaccinia vector efficiently expresses recombinant genes. PNAS USA 89:10847–10851
Moss B, Carroll MW, Wyatt LS, Bennink JR, Hirsch V, Golstein S, Elkins WR, Fuerst TR, Lifson JD, Piatak M, Restifo NP, Overwijk W, Chamberlain R, Rosenberg SA and Sutter G (1996) Host range restricted non-replicating vaccinia virus vectors as vaccine candidates. Adv Exp Med Biol 397:7–13
Stittelaar KJ, Kuiken T, de Swart RL, van Amerongen G, Vos HW, Niesters HG, van Schalkwijk P, van der Kwast T, Wyatt LS, Moss B and Osterhaus AD (2001) Safety of modified vaccinia virus Ankara MVA in immune-suppressed macaques. Vaccine 19:3700–3709
Wyatt LS, Earl PL, Eller LA and Moss B (2004). Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. PNAS USA 101:4590–4595
Hoover DM and Lubkowski J (2002) DNA Works: an automated method for designing oligonucleotides for PCRbased gene synthesis. Nucleic Acids Res 30(10):e43
Wyatt LS, Shors ST, Murphy BR and Moss B (1996) Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model. Vaccine 14:1451–1458
Earl PL, Moss B, Wyatt LS and Carroll MW (1998) Current Protocols in Molecular Biology. In: Current protocols in molecular biology. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (Eds.), Greene Publishing Associates and Wiley Interscience, New York 2:16171–16191
Singh RP, Sreenivasa BP, Dhar P, Shah LC and Bandyopadhyay SK (2004) Development of monoclonal antibody based competitive ELISA for detection and titration of antibodies to peste des petits ruminants PPR virus. Vet Microbiol 98(1):3–15
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680–685
Bassiri MS, Ahmad L, Giavedoni L, Jones JT, Saliki CM and Yilma T (1993) Immunological responses of mice and cattle to baculovirus expressed F and H proteins of rinderpest virus: lack of protection in the presence of neutralizing antibody. J Virol 67:1255–1261
Dhinakar RG, Nachimuthu K and Mahalinga NA (2000) A simplified objective method for quantification of peste des petits ruminants virus or neutralizing antibody. J Virol Methods 89(1–2):89–95
OIE Manual of diagnostic tests and vaccines for Terrestrial animals (2006). Chapter 2.1.5. Website: http://www.oie.int/eng/Normes/mmanual/A_00028.htm.
Cox WI, Tartaglia J and Paoletti E (1992) Poxvirus recombinants as live vaccines. In: Recombinant poxviruses. Binns MM, Smith GL (Eds.), Recombinant Poxviruses CRC Press, Boca Raton, Florida, pp 23–162
World Health Organization (1980) The global eradication of smallpox Final report of the global commission for the certification of smallpox eradication History of international public health, No. 4 World Health Organization, Geneva, Switzerland
Miyahira Y, Garc’a-Sastre A, Rodriguez D, Rodriguez JR, Murata K, Tsuji M, Palese P, Esteban M, Zavala F and Nussenzweig RS (1998) Recombinant viruses expressing a human malaria antigen elicit protective immune CD881 T cell responses in mice. PNAS USA 95:3954–3959
Coupar BE, Andrew ME, Both GW and Boyle DB (1986) Temporal regulation of influenza haemagglutin expression in vaccinia virus recombinants and effects of the immune response. Eur J Immunol 16:1479–1487
Good RA and Zak SJ (1956) Disturbances in gamma globulin synthesis as “experiments of nature”. Pediatrics 18:109–114
Zhu Y, Rota P, Wyatt L, Tamin A, Rozenblatt S, Lerche N, Moss B, Bellini W and McChesney M (2000) Evaluation of recombinant vaccinia virus measles vaccines in infant rhesus macaques with preexisting measles antibody. Virology 276:202–213
Inui K, Barrett T, Kitching RP and Yamanouchi K (1995) Long-term immunity in cattle vaccinated with a recombinant rinderpest vaccine. Vet Rec 137:669–670
Ngichabe CK, Wamwayi HM, Barrett T, Ndungu EK, Black DN and Bostock CJ (1997) Trial of a capripoxvirusrinderpest recombinant vaccine in African cattle. Epidemiol Infect 118:63–70
Ohishi K, Inui K, Barrett T and Yamanouchi K (2000) Longterm protective immunity to rinderpest in cattle following a single vaccination with a recombinant vaccinia virus expressing the virus haemagglutinin protein. J Gen Virol 81:1439–1446
Verardi PH, Aziz FH, Ahmad S, Jones LA, Beyene B, Ngotho RN, Wamwayi HM, Yesus MG, Egziabher BG and Yilma TD (2002) Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins. J Virol 76(2):484–491
Sreenivasa BP, Dhar P, Singh RP and Bandyopadhyay SK (2000) Evaluation of an indigenously developed homologous live-attenuated cell culture vaccine against peste des petits ruminants infection of small ruminants. Proc 10th Annual Conference of the Indian Association of Veterinary Microbiologists, Immunologists and Specialists in Infectious Diseases, 14–16 October, Pantnagar, India; GB Pant University of Agriculture and Technology, Pantnagar, 84 pp
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chandran, D., Reddy, K.B., Vijayan, S.P. et al. MVA recombinants expressing the fusion and hemagglutinin genes of PPRV protects goats against virulent challenge. Indian J Microbiol 50, 266–274 (2010). https://doi.org/10.1007/s12088-010-0026-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-010-0026-9